<qa>  What is a STUDY OF TIPRANAVIR CO-ADMINISTEREDAN OPEN LABEL SAFETY STUDY OF TIPRANAVIR CO-ADMINISTERED WITH LOW-DOSE RITONAVIR IN PATIENTS WITH ADVANCED HIV-1 INFECTION AND LIMITED TREATMENT OPTIONS.: 